Federal Official Gazette
ORDINANCE SCTIE/MS No. 65, OF OCTOBER 20, 2026
The Ministry of Health has incorporated into SUS the bone distractors for the treatment of people with craniosynostosis, in accordance with the ministerial protocol.
The technical areas will have a maximum period of 180 days to make the technology available in SUS. The ordinance entered into force on the date of its publication.
Analysis: the ANS Rol already covers the surgical treatment of craniosynostosis, but the ordinance specifically addresses the incorporation of the bone distractors used in the procedure. Because the positive decision of Conitec and the incorporation into SUS have been formally published, Article 10, § 10, of Law No. 9,656/1998 applies, which requires the technology to be included in the Rol within 60 days.
ANS must assess whether the technology requires an express amendment to the Rol or to a Utilization Guideline (Diretriz de Utilização), or whether it is already fully encompassed by the coverage of the existing surgical procedure.
https://www.in.gov.br/web/dou/-/portaria-sctie/ms-n-65-de-20-de-outubro-de-2026-739411149
ANS news
ANS TAKES PART IN DEBATES ON THE FUTURE OF SUPPLEMENTARY HEALTH AT CONAHP 2026
ANS announced its participation in the annual congress of the Associação Nacional de Hospitais Privados (National Association of Private Hospitals), held on October 14 and 15.
The Agency’s Chief Executive Officer (diretor-presidente), Wadih Damous, argued that regulation should move from a predominantly normative and enforcement role to one that drives transformation, sustainability and innovation. The panel also included Marcos Novais, executive director of Abramge, as well as representatives of Interfarma and Anahp.
Open public consultations
- CP 178. Subject matter: preliminary recommendations against the incorporation of somatrogon and cabozantinib levomalate. Deadline: from October 7 to October 26, 2026
- CP 179. Subject matter: proposed update of ANS Normative Instruction – IN ANS No. 31, of December 19, 2022, which governs the monitoring and assessment of the guarantee of care for beneficiaries by health plan operators. Deadline: from Oct 23, 2026 to Dec 7, 2026
Scheduled public hearings
There are no scheduled public hearings.
Open public calls for input
There are no scheduled public hearings.
Open public calls
There are no open public calls or targeted social participation procedures.
Other news
Supreme Court will review judicial revision of amounts paid by SUS to private hospitals
The Plenary followed the opinion of the rapporteur, Justice Gilmar Mendes, and recognized the general repercussion of the dispute, which may affect the public health budget
The dispute involves a request by the hospitals that the remuneration for services provided to SUS be calculated based on the Tabela Única Nacional de Equivalência de Procedimentos (Tunep) and the Índice de Valoração do Ressarcimento (IVR), parameters of the National Supplementary Health Agency (ANS) used to define how much health plans must reimburse the public system when their beneficiaries are treated in the public network. In the case to be decided by the Supreme Court, the appellant is the Santa Casa de Misericórdia de Juiz de Fora (MG).
Sources: Federal Official Gazette (DOU) and the ANS website. Press items link to the original article. This brief is for information only and does not constitute legal advice.